Poor metabolic and blood pressure control in patients with diabetic retinopathy attending a tertiary ophthalmic hospital in Australia

Diabetes Research and Clinical Practice
Gabriella TikellisTien Y Wong

Abstract

To determine the adherence to recommended glycemic and blood pressure levels in patients with diabetic retinopathy (DR). A retrospective study in a tertiary eye clinic in Melbourne, Australia. Data pertaining to blood pressure (BP) and glycosylated hemoglobin (HbA1c) level were extracted from charts over a 3-month period. Optimal HbA1c was defined as levels <7%, and optimal BP control was defined as systolic/diastolic <130/80mmHg. Of the 483 patients with DR in this study, only 54% (259/482) had a recorded HbA1c measurement. Of these, only 14% (36/259) had an optimal HbA1c level. Patients with longer diabetes duration were less likely to attain optimal HbA1c levels (age and gender adjusted odds ratio (OR) 0.23; 95% confidence intervals (CIs) 0.08-0.71 for diabetes duration 11-19 years, and OR 0.18%, 95% CI 0.06-0.58 for duration >20 years versus </=5 years). Optimal BP control was attained in only 18% (86/483) and was associated with younger age (OR 0.98; 95% CI 0.96-0.99, per year increase in age). Adherence to clinical guidelines for glycemic and BP control in patients with DR was low, even in a well-developed healthcare system with free ophthalmic care access.

References

Sep 30, 1993·The New England Journal of Medicine·UNKNOWN Diabetes Control and Complications Trial Research GroupC Siebert
Feb 22, 2001·Diabetes Research and Clinical Practice·J OverlandM Mira
May 27, 2003·Diabetes Care·Robyn J TappUNKNOWN AusDiab Study Group
Jan 22, 2004·JAMA : the Journal of the American Medical Association·Sharon H SaydahCatherine C Cowie
Sep 24, 2005·Diabetic Medicine : a Journal of the British Diabetic Association·B EliassonUNKNOWN Steering Committee of the Swedish National Diabetes Register
Mar 9, 2007·Diabetes Research and Clinical Practice·Nish Chaturvedi
Aug 23, 2007·JAMA : the Journal of the American Medical Association·Quresh MohamedTien Y Wong

❮ Previous
Next ❯

Citations

Dec 18, 2013·Middle East African Journal of Ophthalmology·Peter H ScanlonIrene M Stratton
Feb 4, 2010·Diabetic Medicine : a Journal of the British Diabetic Association·Y ZhangA Gilbert
Apr 7, 2016·Journal of Ophthalmic & Vision Research·Zhaleh RajaviKourosh Sheibani
Dec 21, 2016·Journal of Ophthalmic & Vision Research·Zhale RajaviFaegheh Golbafian
Jun 26, 2013·Optometry and Vision Science : Official Publication of the American Academy of Optometry·Eva K FenwickGwyn Rees

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.